Clinical Trial Update: A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tolerability and efficacy of different duloxetine doses in adults with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder | Phase 4 | Status: COMPLETED